ArticleCureus2026
Case Series of Rare Uterine Smooth Muscle Tumors: Diagnostic Challenges and Clinical Implications.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uterine smooth muscle tumors exhibit a wide range of pathological forms and biological behaviors. While leiomyomas are typically benign and frequently encountered, there exist rare variants and malignant counterparts that present notable diagnostic and therapeutic challenges. This case series explores a diverse group of uterine smooth muscle tumors, including leiomyomas with elevated mitotic figures, uterine tumors resembling ovarian sex cord tumors (UTROSCT), smooth muscle tumors of uncertain malignant potential (STUMP), myxoid leiomyosarcoma, and inflammatory leiomyosarcoma. Each case is described with a focus on histopathological features, immunohistochemical profile, clinical presentation, and corresponding management. The series underscores the importance of precise pathological categorization in guiding individualized treatment approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.